The Royal Wolverhampton NHS Trust runs New Cross Hospital and West Park Rehabilitation Hospital in Wolverhampton and Cannock Chase Hospital in Cannock.

During the past decade, The Royal Wolverhampton NHS Trust conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 17 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 11 clinical trials were completed. i.e. 57.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Royal Wolverhampton NHS Trust" #1 sponsor was "The Royal Wolverhampton Hospitals NHS Trust" with 25 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Royal Wolverhampton NHS Trust" #1 collaborator was "Guy's and St Thomas' NHS Foundation Trust" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Oxford University Hospitals NHS Trust" with 2 trials as a collaborator, "University of Oxford" with 2 trials as a collaborator and "University of Wolverhampton" with 2 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "The Royal Wolverhampton NHS Trust" are "Multiple Myeloma" (6 trials), "Covid19" (3 trials), "Aortic Valve Stenosis" (2 trials), "Colitis, Ulcerative" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "The Royal Wolverhampton NHS Trust" in a lesser frequency.

Most popular intervention types in "The Royal Wolverhampton NHS Trust" are "Drug" (28 trials), "Other" (18 trials), "Device" (10 trials), "Diagnostic Test" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (5 trials), "Placebo" (4 trials), "Bortezomib" (2 trials), "Carfilzomib" (2 trials) and "Interview" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Royal Wolverhampton NHS Trust" are 60 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Royal Wolverhampton NHS Trust". 2 are not yet recruiting, 10 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in The Royal Wolverhampton NHS Trust, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in The Royal Wolverhampton NHS Trust, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 18 trials that are defined as “Not Applicable".

The Royal Wolverhampton NHS Trust has several departments that took part in Clinical trials: "New Cross Hospital; Deansley Centre" - 6 trials, "New Cross Hospital; Dept. Of Haematology" - 4 trials, "Heart and Lung Centre, New Cross Hospital" - 2 trials, "Diabetes Centre, New Cross Hospital" - 2 trials